Toll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activity.
about
A diverse array of genetic factors contribute to the pathogenesis of systemic lupus erythematosusPattern Recognition Receptors in Cancer Progression and MetastasisContribution of toll-like receptor signaling pathways to breast tumorigenesis and treatmentDrosophila at the intersection of infection, inflammation, and cancerMucins and toll-like receptors: kith and kin in infection and cancerThe Yin and Yang of Toll-like receptors in cancerClients and Oncogenic Roles of Molecular Chaperone gp96/grp94The Role of Anti-DNA Antibodies in the Development of Lupus Nephritis: A Complementary, or Alternative, Viewpoint?Comparative proteomics study reveals that bacterial CpG motifs induce tumor cell autophagy in vitro and in vivoExpression-based Pathway Signature Analysis (EPSA): mining publicly available microarray data for insight into human disease.Anti-dsDNA antibodies promote initiation, and acquired loss of renal Dnase1 promotes progression of lupus nephritis in autoimmune (NZBxNZW)F1 mice.Bacteria peptidoglycan promoted breast cancer cell invasiveness and adhesiveness by targeting toll-like receptor 2 in the cancer cellsExpression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells.TLR9 expression in glioma tissues correlated to glioma progression and the prognosis of GBM patients.Toll-like receptor mediated regulation of breast cancer: a case of mixed blessings.High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer.Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasisEpigallocatechin-3-gallate suppresses proinflammatory cytokines and chemokines induced by Toll-like receptor 9 agonists in prostate cancer cells.Toll-like receptor 9 in breast cancer.Reduced expression of Toll-like receptor 4 inhibits human breast cancer cells proliferation and inflammatory cytokines secretionToll-like receptor 9 mediated responses in cardiac fibroblastsSilencing of renal DNaseI in murine lupus nephritis imposes exposure of large chromatin fragments and activation of Toll like receptors and the Clec4e.Spontaneous production of immunoglobulin M in human epithelial cancer cellsToll-like receptor 9 prevents cardiac rupture after myocardial infarction in mice independently of inflammation.DNA from dead cancer cells induces TLR9-mediated invasion and inflammation in living cancer cellsGenetic variation in TLR or NFkappaB pathways and the risk of breast cancer: a case-control studyActivation of Toll-like receptor-9 promotes cellular migration via up-regulating MMP-2 expression in oral squamous cell carcinoma.Absent Toll-like receptor-9 expression predicts poor prognosis in renal cell carcinomaToll-like receptor 9 expression in breast and ovarian cancer is associated with poorly differentiated tumorsTLR9 differentiates rapidly from slowly progressing forms of idiopathic pulmonary fibrosis.Tissue expression of Toll-like receptors 2 and 4 in sporadic human colorectal cancer.Cell Free DNA of Tumor Origin Induces a 'Metastatic' Expression Profile in HT-29 Cancer Cell Line.Expression of toll-like receptors on breast tumors: taking a toll on tumor microenvironment.Tumor infiltrating CD8(+) T lymphocyte count is independent of tumor TLR9 status in treatment naïve triple negative breast cancer and renal cell carcinomaRecent developments on immunotherapy for brain cancer.Regulation of migration and invasion by Toll-like receptor-9 signaling network in prostate cancer.Toll-like receptor 5 (TLR5) expression is a novel predictive marker for recurrence and survival in squamous cell carcinoma of the tongue.TLR signaling by tumor and immune cells: a double-edged sword.Should a Toll-like receptor 4 (TLR-4) agonist or antagonist be designed to treat cancer? TLR-4: its expression and effects in the ten most common cancersGlomerular matrix metalloproteinases and their regulators in the pathogenesis of lupus nephritis.
P2860
Q22299119-AE19DFED-C834-423B-8BDC-581E92F060E0Q26798034-18D470CF-DDC0-49BA-BE9C-EE557EFF7B43Q26825259-526735F2-15E0-4F41-A634-06712D3F1955Q26827570-795C3F10-F096-4CD8-9140-6CBD193A5C85Q26830597-EDC5FCEC-F980-4A82-A50B-423A3B9E7BFFQ26851526-E31C3892-1136-42F3-8488-B2158EFE685AQ28075479-5BE49734-3055-42C1-9F08-2223BAF77F6EQ28085243-13CAFDCB-3511-422D-8ABE-AD0A17101C21Q28582844-99A9C891-35F1-41B6-9A33-0A8F6448B067Q33378247-30244C6F-331B-4CE4-8B0B-BADA0D26D49EQ33521279-A5F9E378-5DDE-4AA6-A27D-70FBCC4178F4Q33592943-77D9DB72-7A57-42E8-A3D8-4A6713ACDE82Q33609716-6121D3D1-4AFE-46DF-8756-740098966790Q33653031-9C38082E-0F9D-4061-8EE9-E1CFA1550880Q33658124-C4C8007B-7970-48B5-82DD-7F4113B45AABQ33708134-B835DE51-B256-4A81-B51B-6D1980A6F2A4Q33762632-6189391D-732C-460E-B0E8-B87A54129182Q33806328-4BA86DF5-AA65-4387-881D-F67E51328755Q33928402-8420EE0A-49B5-4E14-A4A0-57009A119841Q34036026-B76F0EFD-1201-4E0D-8F7D-E3CD98C22657Q34050642-DC01861B-5305-4D72-826F-701D44762DD5Q34222085-CA11ACA7-67ED-4D06-980F-EBCFB346DDECQ34516619-725F910D-0A03-49FF-8AB3-8B3284BD4DBFQ34543237-740A896B-5599-4B7B-8421-6F52C0041D44Q34549200-D55AE5EA-A481-494C-854E-6E0753B48396Q34698854-F4FE363A-4419-414C-B52F-D8D29721EFB1Q35127878-45BC9622-9015-47B5-AAAD-E67F94E7E0D0Q35241051-843CE5B8-194A-49D1-934A-6688F97AF06AQ35286762-15543003-0A97-49FD-8B59-2C8AF57DBAACQ35606977-A8DD5695-0F9F-410B-9CDA-7DCFC7F04060Q35644136-70DC3179-1070-436A-AF7F-A21EADA0328DQ35680341-322127B9-9EE4-41AB-8B19-A14CF39B9A77Q35684548-0BDD1D86-346C-4B33-8033-844C8BB22FAAQ35798941-A31751EB-A944-422C-9A38-1E384862589DQ35992355-A4C7BC56-387B-410C-9677-04336EAA4F26Q36356021-21475A2D-69AD-471A-8019-777B69105106Q36671862-9A39089E-2E8A-42B8-B32F-28FC844AEAB4Q37051027-F31B233B-0786-4E04-90BF-838374F0F413Q37291780-A9B0C772-C4E1-4127-B30B-A4C5183EE7A4Q37353175-71B19FF6-0266-4504-8100-785C8D975239
P2860
Toll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activity.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Toll-like receptor 9 agonists ...... ix metalloproteinase activity.
@en
type
label
Toll-like receptor 9 agonists ...... ix metalloproteinase activity.
@en
prefLabel
Toll-like receptor 9 agonists ...... ix metalloproteinase activity.
@en
P2093
P1476
Toll-like receptor 9 agonists ...... ix metalloproteinase activity.
@en
P2093
Bradley Gehrs
Brit Shackley
Dongquan Chen
Eben Rosenthal
Joanna M Ilvesaro
Katri S Selander
Kevin W Harris
Melinda A Merrell
Niko Lehtonen
Timo Sorsa
P304
P356
10.1158/1541-7786.MCR-06-0007
P577
2006-07-01T00:00:00Z